MARKET

TARX

TARX

Tarsier Pharma Ltd.
NYSE
9.00
0.00
0.00%
Closed
OPEN
--
PREV CLOSE
9.00
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
263.63M
P/E (TTM)
-3.9823
1D
5D
1M
3M
1Y
5Y
1D
Opening Day: SK Hynix makes loud U.S. arrival in otherwise quiet week for IPOs
TipRanks · 07/13 16:40
Opening Day: Bending Spoons tops pricing range in market debut
TipRanks · 07/06 14:30
Opening Day: Sinda, Doncasters, DSC Holdings begin trading
TipRanks · 06/30 13:40
Tarsier Pharma 5M share IPO price range $8.00-$10.00
TipRanks · 06/23 14:45
Opening Day: SpaceX jumps on first day of trading, surges past $2T
TipRanks · 06/15 15:07
About TARX
Tarsier Pharma Ltd is an Israel-based biopharmaceutical company. The Company is focused on developing and commercializing novel immunomodulatory therapies for the treatment of autoimmune and inflammatory ocular diseases. The Company’s platform is based on dazdotuftide (TRS), a bio‑inspired molecule designed to re‑engineer immune responses and address underlying inflammatory pathways associated with eye disorders. The Firm targets conditions such as non‑infectious anterior uveitis, uveitic glaucoma and other inflammatory eye diseases, with drug candidates being developed for administration via eye drops and intravitreal injections. The Company aims to provide safer and more effective alternatives to existing treatments for conditions that can lead to vision loss and blindness and affect a large global patient population.

Webull offers Tarsier Pharma Ltd stock information, including NYSE: TARX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TARX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TARX stock methods without spending real money on the virtual paper trading platform.